These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 22122881)

  • 1. Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy.
    Hauger RL; Olivares-Reyes JA; Dautzenberg FM; Lohr JB; Braun S; Oakley RH
    Neuropharmacology; 2012 Feb; 62(2):705-14. PubMed ID: 22122881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desensitization of human CRF2(a) receptor signaling governed by agonist potency and βarrestin2 recruitment.
    Hauger RL; Olivares-Reyes JA; Braun S; Hernandez-Aranda J; Hudson CC; Gutknecht E; Dautzenberg FM; Oakley RH
    Regul Pept; 2013 Sep; 186():62-76. PubMed ID: 23820308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of glucocorticoid regulation and posttraumatic stress disorder--What do we know?
    Castro-Vale I; van Rossum EF; Machado JC; Mota-Cardoso R; Carvalho D
    Neurosci Biobehav Rev; 2016 Apr; 63():143-57. PubMed ID: 26872620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of CRF receptor signaling in stress vulnerability, anxiety, and depression.
    Hauger RL; Risbrough V; Oakley RH; Olivares-Reyes JA; Dautzenberg FM
    Ann N Y Acad Sci; 2009 Oct; 1179():120-43. PubMed ID: 19906236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].
    Auxéméry Y
    Encephale; 2012 Oct; 38(5):373-80. PubMed ID: 23062450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting PTSD: pre-existing vulnerabilities in glucocorticoid-signaling and implications for preventive interventions.
    van Zuiden M; Kavelaars A; Geuze E; Olff M; Heijnen CJ
    Brain Behav Immun; 2013 May; 30():12-21. PubMed ID: 22981834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin-Releasing Factor Receptor 1 Antagonism Is Ineffective for Women With Posttraumatic Stress Disorder.
    Dunlop BW; Binder EB; Iosifescu D; Mathew SJ; Neylan TC; Pape JC; Carrillo-Roa T; Green C; Kinkead B; Grigoriadis D; Rothbaum BO; Nemeroff CB; Mayberg HS
    Biol Psychiatry; 2017 Dec; 82(12):866-874. PubMed ID: 28793974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid receptor pathway components predict posttraumatic stress disorder symptom development: a prospective study.
    van Zuiden M; Geuze E; Willemen HL; Vermetten E; Maas M; Amarouchi K; Kavelaars A; Heijnen CJ
    Biol Psychiatry; 2012 Feb; 71(4):309-16. PubMed ID: 22137507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-exposure and environmental enrichment reveal NPY-Y1 as a possible target for post-traumatic stress disorder.
    Hendriksen H; Bink DI; Daniels EG; Pandit R; Piriou C; Slieker R; Westphal KG; Olivier B; Oosting RS
    Neuropharmacology; 2012 Sep; 63(4):733-42. PubMed ID: 22659471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of corticotropin-releasing factor receptor type 2 in the bed nucleus of stria terminalis improves posttraumatic stress disorder-like symptoms in a model of incubation of fear.
    Elharrar E; Warhaftig G; Issler O; Sztainberg Y; Dikshtein Y; Zahut R; Redlus L; Chen A; Yadid G
    Biol Psychiatry; 2013 Dec; 74(11):827-36. PubMed ID: 23871471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in stress responses: a critical role for corticotropin-releasing factor.
    Bangasser DA; Wiersielis KR
    Hormones (Athens); 2018 Mar; 17(1):5-13. PubMed ID: 29858858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist bias and agonist-dependent antagonism at corticotrophin releasing factor receptors.
    Tasma Z; Wills P; Hay DL; Walker CS
    Pharmacol Res Perspect; 2020 Jun; 8(3):e00595. PubMed ID: 32529807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Traumatic Stress Promotes Hyperalgesia via Corticotropin-Releasing Factor-1 Receptor (CRFR1) Signaling in Central Amygdala.
    Itoga CA; Roltsch Hellard EA; Whitaker AM; Lu YL; Schreiber AL; Baynes BB; Baiamonte BA; Richardson HN; Gilpin NW
    Neuropsychopharmacology; 2016 Sep; 41(10):2463-72. PubMed ID: 27013358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin-releasing factor overexpression gives rise to sex differences in Alzheimer's disease-related signaling.
    Bangasser DA; Dong H; Carroll J; Plona Z; Ding H; Rodriguez L; McKennan C; Csernansky JG; Seeholzer SH; Valentino RJ
    Mol Psychiatry; 2017 Aug; 22(8):1126-1133. PubMed ID: 27752081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological treatment of PTSD - established and new approaches.
    Steckler T; Risbrough V
    Neuropharmacology; 2012 Feb; 62(2):617-27. PubMed ID: 21736888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRF receptor blockade prevents initiation and consolidation of stress effects on affect in the predator stress model of PTSD.
    Adamec R; Fougere D; Risbrough V
    Int J Neuropsychopharmacol; 2010 Jul; 13(6):747-57. PubMed ID: 19751543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology.
    Bangasser DA; Curtis A; Reyes BA; Bethea TT; Parastatidis I; Ischiropoulos H; Van Bockstaele EJ; Valentino RJ
    Mol Psychiatry; 2010 Sep; 15(9):877, 896-904. PubMed ID: 20548297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: evidence from animal models.
    Kehne JH; Cain CK
    Pharmacol Ther; 2010 Dec; 128(3):460-87. PubMed ID: 20826181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of CRF/CRFR1 signaling in the basolateral nucleus of the amygdala contributes to chronic forced swim-induced depressive-like behaviors in rats.
    Chen L; Li S; Cai J; Wei TJ; Liu LY; Zhao HY; Liu BH; Jing HB; Jin ZR; Liu M; Wan Y; Xing GG
    Behav Brain Res; 2018 Feb; 338():134-142. PubMed ID: 29080675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttraumatic stress disorder-like induction elevates β-amyloid levels, which directly activates corticotropin-releasing factor neurons to exacerbate stress responses.
    Justice NJ; Huang L; Tian JB; Cole A; Pruski M; Hunt AJ; Flores R; Zhu MX; Arenkiel BR; Zheng H
    J Neurosci; 2015 Feb; 35(6):2612-23. PubMed ID: 25673853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.